三星医疗收盘上涨4.56%，滚动市盈率13.91倍，总市值331.78亿元

Core Viewpoint - Samsung Medical's stock price increased by 4.56% to 23.61 yuan, with a rolling PE ratio of 13.91, marking a new low in 55 days, and a total market capitalization of 33.178 billion yuan [1][2] Company Summary - Samsung Medical's main business segments include smart power distribution and medical services, with key products such as smart meters, high-end gateway meters, smart terminals, power boxes, communication modules, and various integrated solutions [1] - The company has received multiple accolades, including being recognized as a national-level intellectual property demonstration enterprise and a provincial key enterprise research institute [1] Financial Performance - For the first quarter of 2025, Samsung Medical reported revenue of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33% [2] - The company's gross profit margin stands at 28.90% [2] Industry Comparison - In the electric grid equipment industry, Samsung Medical's PE ratio of 13.91 is significantly lower than the industry average of 38.47 and the median of 41.87 [2] - The company ranks 34th in terms of PE ratio within its industry [1]